Unknown

Dataset Information

0

Anthracyclines in the treatment of patients with early breast cancer.

ABSTRACT:

SUBMITTER: Guarneri V 

PROVIDER: S-EPMC9271479 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Anthracyclines in the treatment of patients with early breast cancer.

Guarneri V V   de Azambuja E E  

ESMO open 20220419 3

Similar Datasets

Unknown Anthracyclines in the treatment of early breast cancer friend or foe?
| S-EPMC9289865 | biostudies-literature
Unknown Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.
| S-EPMC5986630 | biostudies-literature
Unknown Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
| S-EPMC6378927 | biostudies-literature
Unknown Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis.
| S-EPMC12273482 | biostudies-literature
Unknown Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients.
| S-EPMC4608867 | biostudies-literature
Unknown Cardioprotective interventions for cancer patients receiving anthracyclines.
| S-EPMC6457676 | biostudies-literature
Unknown Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.
| S-EPMC9654353 | biostudies-literature
Unknown Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
| S-EPMC10509566 | biostudies-literature
Unknown Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines.
| S-EPMC9844617 | biostudies-literature
Unknown Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer.
| S-EPMC11395913 | biostudies-literature